Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology Indian Medical PG Practice Questions and MCQs

Question 131: Which non-selective beta blocker is commonly used in the management of glaucoma?

A. Timolol (Correct Answer)
B. Metoprolol
C. Betaxolol
D. Propranolol

Explanation: **Explanation:** **Timolol** is the gold standard and most commonly used non-selective beta-blocker in the management of Open-Angle Glaucoma. It works by blocking $\beta_2$ receptors on the **ciliary epithelium**, thereby reducing the production of aqueous humor. Since it does not affect pupil size or accommodation, it is preferred over miotics. **Analysis of Options:** * **Timolol (Correct):** A potent non-selective $\beta_1$ and $\beta_2$ blocker. It is highly effective in lowering intraocular pressure (IOP) but must be used with caution in patients with asthma or COPD due to potential systemic absorption causing bronchospasm. * **Metoprolol:** This is a cardioselective ($\beta_1$) blocker primarily used in systemic hypertension and cardiology; it is not used topically for glaucoma. * **Betaxolol:** This is a **cardioselective ($\beta_1$)** beta-blocker. While used in glaucoma, it is less effective at lowering IOP than Timolol. However, it is the safest topical beta-blocker for patients with mild respiratory issues because it lacks $\beta_2$ antagonist activity. * **Propranolol:** Although a non-selective beta-blocker, it possesses significant local anesthetic (membrane-stabilizing) activity, which can cause corneal anesthesia and damage if applied topically. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Decreased aqueous secretion (not increased outflow). * **Side Effects:** Bradycardia, heart block, and bronchospasm (due to systemic absorption via the nasolacrimal duct). * **Tip:** To minimize systemic absorption, patients should be advised to perform **punctal occlusion** for 2 minutes after instillation. * **Contraindications:** Bronchial asthma, COPD, 2nd/3rd-degree heart block, and overt heart failure.

Question 132: All of the following are criteria for high risk of developing chloroquine retinopathy except:

A. Duration of use > 5 years
B. Dose of > 250mg/d or > 3mg/kg
C. > 480g total dose (Correct Answer)
D. Presence of renal failure

Explanation: **Explanation:** Chloroquine (CQ) and Hydroxychloroquine (HCQ) are known for causing irreversible maculopathy (Bull’s eye maculopathy). The risk assessment for toxicity has evolved significantly with the **2016 American Academy of Ophthalmology (AAO) guidelines**, which shifted the focus from cumulative dose to daily dose relative to body weight. **Why Option C is the correct answer:** The criteria for "high risk" regarding cumulative dose has been updated. For **Hydroxychloroquine**, the high-risk threshold is a cumulative dose of **>1000g**. For **Chloroquine**, while cumulative dose was historically used, the current primary screening focus is on the daily dose and duration. A cumulative dose of >480g was an older benchmark; however, in the context of this question, it is considered the "least" accurate or outdated criterion compared to the established risk factors of duration, daily dose, and organ failure. **Analysis of Incorrect Options:** * **A. Duration of use > 5 years:** This is a major risk factor. The risk of toxicity is very low (<1%) during the first 5 years but increases significantly thereafter. * **B. Dose of > 250mg/d or > 3mg/kg:** For Chloroquine, a daily dose exceeding **2.3 mg/kg (real weight)** or a standard tablet of 250mg/day is considered high risk. (For HCQ, the limit is >5.0 mg/kg). * **D. Presence of renal failure:** Both drugs are cleared by the kidneys. Decreased GFR increases the drug's half-life and systemic concentration, significantly raising the risk of retinal toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Granular pigmentary changes in the macula. * **Classic Sign:** **Bull’s Eye Maculopathy** (ring-shaped depigmentation of RPE sparing the fovea). * **Screening Tests:** The gold standard for screening is **Automated Visual Fields (10-2)** and **Spectral Domain-OCT (SD-OCT)**. Multifocal ERG (mfERG) is also highly sensitive. * **Amsler Grid:** No longer recommended as a primary screening tool due to low sensitivity.

Question 133: Which of the following antiglaucoma drugs can lead to drowsiness?

A. Apraclonidine
B. Dipevefrine
C. Timolol
D. Brimonidine (Correct Answer)

Explanation: **Explanation:** **Brimonidine** is a highly selective **Alpha-2 (α2) adrenergic agonist**. Unlike its predecessor, Apraclonidine, Brimonidine is more lipophilic, allowing it to cross the **blood-brain barrier (BBB)**. Once in the central nervous system, it stimulates α2 receptors in the brainstem, leading to a reduction in sympathetic outflow. This central action commonly results in **drowsiness, fatigue, and lethargy**. Due to this CNS penetration, Brimonidine is strictly **contraindicated in children under 2 years of age**, as it can cause life-threatening apnea, bradycardia, and profound sedation (somnolence). **Analysis of Incorrect Options:** * **Apraclonidine:** While also an α2 agonist, it is more polar and does not cross the BBB effectively. Its primary side effects are local (allergic blepharoconjunctivitis). * **Dipivefrin:** A prodrug of epinephrine (non-selective α and β agonist). It is more likely to cause systemic sympathetic effects like tachycardia or arrhythmias rather than drowsiness. * **Timolol:** A non-selective β-blocker. Its systemic side effects are primarily cardiovascular (bradycardia) and respiratory (bronchospasm), not typically drowsiness. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Brimonidine reduces IOP by both decreasing aqueous humor production and increasing uveoscleral outflow. * **Neuroprotection:** It is often cited as having potential neuroprotective properties for the optic nerve. * **Follicular Conjunctivitis:** This is the most common local side effect of Brimonidine. * **Contraindication:** Avoid in patients taking Monoamine Oxidase Inhibitors (MAOIs) due to the risk of hypertensive crisis.

Question 134: Spring catarrh is treated with which of the following drugs?

A. Olopatadine drops (Correct Answer)
B. Normal saline eye drops
C. Ciprofloxacin
D. Carboxymethylcellulose (CMC) eye drops

Explanation: **Explanation:** **Spring Catarrh**, also known as **Vernal Keratoconjunctivitis (VKC)**, is a bilateral, recurrent, seasonal allergic inflammation of the conjunctiva, typically affecting young males. It is a Type I (IgE-mediated) and Type IV (cell-mediated) hypersensitivity reaction. **Why Olopatadine is the correct answer:** Olopatadine is the drug of choice because it is a **dual-action agent**. It acts as both a **potent H1-receptor antagonist** and a **mast cell stabilizer**. This dual mechanism provides rapid relief from itching (antihistamine effect) while preventing the further release of inflammatory mediators like histamine, leukotrienes, and prostaglandins (mast cell stabilization). It is highly effective for the long-term management of allergic conjunctivitis with a superior safety profile compared to steroids. **Analysis of Incorrect Options:** * **B. Normal saline eye drops:** These provide only temporary symptomatic relief by washing away allergens and cooling the ocular surface. They do not treat the underlying allergic pathophysiology. * **C. Ciprofloxacin:** This is a fluoroquinolone antibiotic. It is used for bacterial infections (e.g., bacterial conjunctivitis or corneal ulcers) and has no role in treating allergic conditions like VKC. * **D. Carboxymethylcellulose (CMC):** This is a lubricant (artificial tear) used for Dry Eye Disease. While it may soothe the eye, it does not address the mast cell degranulation central to VKC. **Clinical Pearls for NEET-PG:** * **Hallmark signs:** Cobblestone/Giant papillae (Palpebral form) and Horner-Trantas dots (Limbal form). * **Characteristic discharge:** "Ropy" or "stringy" discharge. * **Shield Ulcer:** A sterile, indolent oval ulcer in the upper cornea, a serious complication of VKC. * **Treatment Escalation:** For acute exacerbations, topical steroids (e.g., Fluorometholone) are used. For steroid-sparing long-term therapy, topical Cyclosporine or Tacrolimus is preferred.

Question 135: Which drug should be avoided in a case of spring catarrh?

A. Methylcellulose eyedrops
B. Antibiotics (Correct Answer)
C. Steroids
D. Antihistamine

Explanation: **Explanation:** **Spring Catarrh (Vernal Keratoconjunctivitis - VKC)** is a bilateral, recurrent, seasonal allergic inflammation of the conjunctiva, primarily driven by a Type I hypersensitivity reaction to allergens like pollen. **Why Antibiotics are avoided:** The underlying pathology of VKC is **allergic**, not bacterial. Antibiotics have no therapeutic role in treating an allergy. Furthermore, their unnecessary use is contraindicated because: 1. They can cause **medicamentosa** (drug-induced conjunctivitis), worsening the patient's discomfort. 2. They contribute to **antimicrobial resistance**. 3. They may cause hypersensitivity reactions in an already sensitized ocular surface. **Analysis of Incorrect Options:** * **Methylcellulose (Lubricants):** These are beneficial as they provide a barrier against allergens and wash away inflammatory mediators from the ocular surface. * **Steroids:** These are the "gold standard" for managing acute exacerbations of VKC due to their potent anti-inflammatory action. However, they must be used under supervision to avoid glaucoma and cataracts. * **Antihistamines:** These are a mainstay of treatment (often combined with mast cell stabilizers) to provide symptomatic relief from itching. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark symptoms:** Intense itching, ropy discharge, and photophobia. * **Key signs:** Cobblestone papillae (Palpebral form), Horner-Trantas dots (Limbal form), and Shield ulcers (Corneal involvement). * **Treatment Ladder:** Mast cell stabilizers (Cromolyn) for prophylaxis → Topical Antihistamines → Topical Steroids (for pulses) → Cyclosporine/Tacrolimus (for steroid-sparing).

Question 136: Which of the following drugs should not be given in a patient with acute angle-closure glaucoma?

A. Pilocarpine
B. Clozapine (Correct Answer)
C. Fluphenazine
D. Paroxetine

Explanation: In acute angle-closure glaucoma (AACG), the primary goal is to reduce intraocular pressure (IOP) and open the drainage angle. Drugs with **anticholinergic (parasympatholytic)** properties are strictly contraindicated because they cause mydriasis (pupil dilation), which further crowds the angle and worsens the blockage. **Explanation of the Correct Answer:** * **B. Clozapine:** This is an atypical antipsychotic known for its potent **anticholinergic side effects**. By blocking muscarinic receptors, it causes mydriasis, which can precipitate or exacerbate an attack of angle-closure glaucoma. While many psychotropic drugs carry this risk, Clozapine is particularly noted for its high anticholinergic burden. **Explanation of Incorrect Options:** * **A. Pilocarpine:** This is a **miotic (parasympathomimetic)** drug. It is a mainstay treatment for AACG because it constricts the pupil, pulling the peripheral iris away from the trabecular meshwork to open the angle. (Note: It is usually avoided if IOP is >40-50 mmHg due to ischemia of the iris sphincter). * **C. Fluphenazine:** This is a typical antipsychotic (high potency). While it has some side effects, its anticholinergic profile is significantly lower than that of Clozapine or low-potency antipsychotics like Chlorpromazine. * **D. Paroxetine:** Although SSRIs can occasionally trigger glaucoma via weak serotonergic mechanisms, Clozapine’s direct and powerful anticholinergic action makes it the more definitive "do not give" drug in this clinical context. **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatics (Atropine, Cyclopentolate)** and **Sympathomimetics (Adrenaline)** are contraindicated in AACG. * **Drug of choice for immediate IOP reduction:** IV Acetazolamide or Hyperosmotic agents (Mannitol). * **Definitive treatment for AACG:** Peripheral Iridotomy (usually YAG laser). * **Clozapine Monitoring:** Remember the risk of **Agranulocytosis** (requires mandatory WBC monitoring) and seizures.

Question 137: Which of the following medications increases aqueous humor outflow?

A. Timolol
B. Latanoprost (Correct Answer)
C. Atropine
D. Dorzolamide

Explanation: **Explanation:** The management of intraocular pressure (IOP) involves either decreasing aqueous humor production or increasing its drainage (outflow). **Correct Answer: B. Latanoprost** Latanoprost is a **Prostaglandin F2α analog**. It is the drug of choice for Primary Open Angle Glaucoma (POAG) because it significantly increases aqueous drainage via the **Uveoscleral pathway** (the unconventional route). It works by remodeling the extracellular matrix in the ciliary muscle, reducing resistance to flow. **Incorrect Options:** * **A. Timolol:** A non-selective **Beta-blocker**. It reduces IOP by **decreasing the production** of aqueous humor from the ciliary body epithelium. It does not affect outflow. * **C. Atropine:** An **Anticholinergic (Mydriatic)**. It can actually decrease outflow by causing mydriasis, which may crowd the angle and precipitate acute angle-closure glaucoma in predisposed eyes. * **D. Dorzolamide:** A topical **Carbonic Anhydrase Inhibitor**. Like beta-blockers, it works by **decreasing the secretion** of aqueous humor by inhibiting the enzyme necessary for bicarbonate production in the ciliary processes. **High-Yield Clinical Pearls for NEET-PG:** * **Uveoscleral Outflow:** Increased by Prostaglandins (Latanoprost, Bimatoprost) and Alpha-agonists (Apraclonidine, Brimonidine). * **Trabecular Outflow:** Increased by Miotics (Pilocarpine) by contracting the ciliary muscle and opening the trabecular meshwork. * **Side Effects of Latanoprost:** Increased iris pigmentation (heterochromia), hypertrichosis (thickening of eyelashes), and cystoid macular edema (CME). * **Contraindication:** Avoid Beta-blockers (Timolol) in patients with Asthma or Heart Block.

Question 138: Which agent is used to prevent synechiae after DCR surgery?

A. Mitomycin (Correct Answer)
B. Tacrolimus
C. Cyclosporine
D. Doxycycline

Explanation: **Explanation:** **Mitomycin C (MMC)** is the correct answer. In the context of Dacryocystorhinostomy (DCR), the primary cause of surgical failure is the formation of fibrous tissue and **synechiae** (adhesions) at the osteotomy site or between the nasal septum and the middle turbinate. MMC is a potent antimetabolite derived from *Streptomyces caespitosus* that inhibits fibroblast proliferation and collagen synthesis by cross-linking DNA. Intraoperative application of low-dose MMC (typically 0.2–0.5 mg/ml) to the osteotomy site significantly reduces scarring, maintains the patency of the stoma, and prevents synechiae formation. **Analysis of Incorrect Options:** * **Tacrolimus:** A calcineurin inhibitor used primarily for refractory vernal keratoconjunctivitis (VKC) or preventing corneal graft rejection. It does not have a primary role in preventing post-DCR fibrosis. * **Cyclosporine:** Another calcineurin inhibitor used for dry eye (Sjögren’s) and VKC. Like Tacrolimus, it modulates T-cell activity but is not used to prevent mechanical synechiae in lacrimal surgery. * **Doxycycline:** An antibiotic with anti-matrix metalloproteinase (MMP) properties. While used in ocular rosacea and persistent epithelial defects, it is not used to prevent adhesions in DCR. **High-Yield Clinical Pearls for NEET-PG:** * **Other uses of MMC in Ophthalmology:** Glaucoma filtering surgery (Trabeculectomy) to prevent bleb failure, Pterygium excision (to prevent recurrence), and Haze prevention after PRK (refractive surgery). * **DCR Success:** The most common site of failure in DCR is the **rhinostomy (stoma) site** due to granulation tissue. * **Alternative:** 5-Fluorouracil (5-FU) is another antimetabolite, but MMC is more potent and more commonly used in DCR.

Question 139: Which mydriatic is used for refraction in infants?

A. Atropine ointment (Correct Answer)
B. Atropine drops
C. Homatropine
D. Eucatropine

Explanation: **Explanation:** In infants and young children, the ciliary muscle is highly active and has strong accommodative power. To obtain an accurate refractive error (cycloplegic refraction), a potent cycloplegic is required to completely paralyze the ciliary muscle. **Why Atropine Ointment is the Correct Choice:** 1. **Potency:** Atropine (1%) is the most powerful cycloplegic available, making it the gold standard for children under 5–7 years of age, especially those with suspected accommodative esotropia. 2. **Safety in Infants:** In infants, **ointment is preferred over drops** to minimize systemic absorption. Drops can easily drain through the nasolacrimal duct into the highly vascular nasal mucosa, leading to systemic toxicity (tachycardia, flushing, fever). Ointment stays in the conjunctival sac, provides a sustained effect, and has a lower risk of systemic side effects. **Analysis of Incorrect Options:** * **Atropine Drops:** While effective for cycloplegia, they carry a significantly higher risk of systemic toxicity in infants due to rapid absorption via the nasolacrimal duct. * **Homatropine:** This is a weaker cycloplegic with a shorter duration of action. It is insufficient to overcome the strong accommodative reflex in infants. * **Eucatropine:** This is a weak mydriatic with very little cycloplegic action, making it unsuitable for refraction in children. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen:** Atropine 1% ointment is typically applied twice daily for 3 days prior to the refraction. * **Atropine Toxicity Mnemonic:** "Mad as a hatter (delirium), Red as a beet (flushing), Dry as a bone (decreased secretions), Hot as a hare (hyperthermia), and Blind as a bat (cycloplegia)." * **Antidote:** Physostigmine is the specific antidote for atropine poisoning. * **Drug of Choice for School-aged Children:** Cyclopentolate 1% is generally preferred for older children (7–15 years) as it has a faster onset and shorter duration than atropine.

Question 140: Ethambutol toxicity primarily affects which aspect of vision?

A. Red vision
B. Green vision (Correct Answer)
C. Yellow vision
D. Blue vision

Explanation: **Explanation:** Ethambutol is a key bacteriostatic drug used in the treatment of Tuberculosis. Its most significant side effect is **dose-dependent optic neuropathy**, which typically presents as a retrobulbar neuritis. **Why Green Vision is Correct:** The earliest clinical sign of ethambutol-induced optic toxicity is a defect in **color vision**, specifically **Red-Green dyschromatopsia**. Among the two, **Green color blindness (deuteranopia)** is often the earliest detectable change. This occurs due to the toxic effect of the drug on the papillomacular bundle of the optic nerve, leading to central or centrocecal scotomas and reduced visual acuity. **Analysis of Incorrect Options:** * **Red Vision (A):** While red-green color blindness occurs, green perception is typically affected first or more prominently in early screening. * **Yellow Vision (C):** Known as xanthopsia, this is classically associated with **Digitalis (Digoxin) toxicity**, not ethambutol. * **Blue Vision (D):** Known as cyanopsia, this is a common side effect of **Sildenafil (Viagra)** due to its inhibition of PDE-6 in the retina. **Clinical Pearls for NEET-PG:** * **Dose:** Toxicity is rare at 15 mg/kg but increases significantly at doses >25 mg/kg. * **Monitoring:** Patients on Ethambutol must undergo baseline and monthly ophthalmic examinations, including **Snellen’s chart** for acuity and **Ishihara plates** for color vision. * **Reversibility:** The toxicity is generally reversible if the drug is discontinued immediately upon the onset of symptoms. * **Mechanism:** It is thought to act as a chelating agent that disrupts copper metabolism within the mitochondria of optic nerve axons.

Practice by Chapter

Ocular Pharmacokinetics

Practice Questions

Anti-infective Agents

Practice Questions

Anti-inflammatory Drugs

Practice Questions

Antiglaucoma Medications

Practice Questions

Mydriatics and Cycloplegics

Practice Questions

Ocular Lubricants

Practice Questions

Anti-VEGF Agents

Practice Questions

Ocular Diagnostic Agents

Practice Questions

Anesthetics in Ophthalmology

Practice Questions

Preservatives and Their Effects

Practice Questions

Ocular Toxicology

Practice Questions

Novel Drug Delivery Systems

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free